At the “National Key Laboratory of Advanced Medical Materials and Medical Devices” in Tianjin, a scientific research team with an average age of less than 30 is using cell culture and 3D printing technology to “grow” organs such as the liver and heart in culture dishes, exploring new paths for human health.

At this national key laboratory at the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, a research team has already been able to “manufacture” five bioartificial organs: liver, heart, kidney, lung, and skin . These artificial organs are currently being applied in drug development. For example, researchers are currently testing the safety of a drug for treating acute liver failure using an “artificial liver.”

For a drug to make it from the laboratory to the clinic, it requires extensive testing. In the past, preclinical research relied primarily on animal experiments, which took months or even years . Now, research teams are using artificial organs to overcome this bottleneck, significantly shortening the drug development cycle .

Deng Bo, a researcher at the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, stated: “From manufacturing to drug screening, artificial organs can be completed in roughly 72 hours. I think the most important point is that there are species differences between animals and humans. To a certain extent, I believe our artificial organs are closer to real therapeutic effects (drug responses).”

Artificial organs not only improve research and development efficiency but also carry the ultimate goal of saving patients. Researchers’ ultimate goal is to achieve autologous transplantation of artificial organs to serve more patients. Currently, they are collaborating with clinicians to overcome technical challenges such as constructing vascular networks for artificial organs.

This scientific research innovation is application-oriented and aims to make it affordable and useful to everyone.

Context for the new conspiracy theory -> https://lemmygrad.ml/post/9008185